Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2003
03/20/2003CA2459586A1 Bacterial cells and vaccines comprising three or more colisurface antigens
03/20/2003CA2459426A1 Human immunodeficiency virus envelope glycoprotein mutants and uses thereof
03/20/2003CA2459318A1 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003CA2459310A1 Method and composition for treating immune complex associated disorders
03/20/2003CA2457848A1 Use of 4-pyridylmethylphthalazines for cancer treatment
03/20/2003CA2457441A1 Infectious and attenuated bovine viral diarrhea virus clone; methods for their production and use
03/20/2003CA2457287A1 Production and use of human cd124 and cd116 positive tumour cell lines in the production of allogenic or semi-allogenic immunotherapy agents
03/20/2003CA2456561A1 Multiplication of viruses in a cell culture
03/20/2003CA2455990A1 Methods for diagnosing and treating diseases and conditions associated with protein kinase c.lambda.
03/20/2003CA2451454A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/19/2003EP1293212A1 Anti cancer vaccine comprising whole cancer cells with modified sialic acid
03/19/2003EP1293205A1 Valproic acid and derivatives thereof for the combination therapy of human cancers, for the treatment of tumour metastasis and minimal residual disease
03/19/2003EP1292694A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
03/19/2003EP1292687A2 Regulated antigen delivery system (rads) involving bacteria
03/19/2003EP1292686A1 Gene expression cassette and its use
03/19/2003EP1292683A2 Secreted redox proteins
03/19/2003EP1292681A1 Antigenic polypeptides
03/19/2003EP1292680A2 Agonist anti-trk-c monoclonal antibodies
03/19/2003EP1292676A1 Mutation associated with epilepsy
03/19/2003EP1292675A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
03/19/2003EP1292674A2 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
03/19/2003EP1292668A2 Gene disruption methodologies in fungi for drug target discovery
03/19/2003EP1292621A1 Compositions and methods for the endocytic presentation of immunosuppressive factors
03/19/2003EP1292619A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
03/19/2003EP1292615A2 Modified morbillivirus v proteins
03/19/2003EP1292591A2 Substituted bicyclic derivatives for the treatment of abnormal cell growth
03/19/2003EP1292334A1 Bispecific fusion protein and method of use for enhancing effector cell killing of target cells
03/19/2003EP1292333A1 Adjuvant composition comprising fha protein or fragment of fha protein in free form
03/19/2003EP1292332A2 Adjuvants and processes to induce a specific type of immune response
03/19/2003EP1292331A2 Immunostimulatory rna/dna hybrid molecules
03/19/2003EP1292330A1 Immunostimulating properties of a fragment of tgf- beta
03/19/2003EP1292329A1 Manipulation of negative stranded rna viruses by rearrangement of their genes and uses thereof
03/19/2003EP1292328A1 Chimeric human papillomavirus (hpv) l1 molecules and uses therefor
03/19/2003EP1292327A2 IMMUNIZATION OF DAIRY CATTLE WITH Mig PROTEIN
03/19/2003EP1292322A1 Immunosuppressor agent derived from morbillivirus
03/19/2003EP1292321A1 Method to increase class i presentation of exogenous antigens by human dendritic cells
03/19/2003EP1292289A2 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
03/19/2003EP1292285A1 Delivery systems for bioactive agents
03/19/2003EP1082344B1 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
03/19/2003EP0964697B1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene
03/19/2003EP0957935B1 Chlamydial vaccines and immunogenic compositions containing an outer membrane antigen and method of preparation thereof
03/19/2003EP0936921B1 Two-step immunization procedure against the pyramyxoviridae family of viruses using attenuated viral strains and subunit protein preparation
03/19/2003EP0917472B1 Antiprotozoal composition
03/19/2003EP0876482B1 Il-13 receptor polypeptide
03/19/2003EP0871490B1 Branched hydrazone linkers
03/19/2003EP0865609B1 Method of diagnosing and treating epithelioma
03/19/2003EP0725789B1 Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition
03/19/2003EP0722463B1 Methods and composition for the modulation of host immune response to allergens
03/19/2003EP0670904B1 Vector for the expression of therapy-relevant genes
03/19/2003EP0669971B1 Method of producing gram-negative bacterial vaccines
03/19/2003EP0667902B1 Cdr grafted humanised chimeric t-cell antibodies
03/19/2003EP0595935B1 Papillomavirus Vaccine
03/19/2003EP0556333B1 Avirulent salmonella microbes comprising a mutation in the cdt gene and uses therefor
03/19/2003EP0522138B1 Influenza virus vaccine composition and containing influenza virus core as an additive having a synergistic effect
03/19/2003EP0463101B2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
03/19/2003CN1404488A NOGO receptor-mediated blockade of axonal growth
03/19/2003CN1404400A Use of IL-18 inhibitors
03/19/2003CN1404399A Novel non-antigenic mucosal adjuvant formulation for modulating the effects of substances, including vaccine antigens in contact with mucosal body surface
03/19/2003CN1404398A Improved DNA vaccines for production-type animals
03/19/2003CN1403574A Modified EB virus LMP1 coding sequence and its prepn and application
03/19/2003CN1403484A Prepn and application of transmembrane staphylococcus aureus toxin A fusion protein
03/18/2003USRE38037 Modular semiconductor power device
03/18/2003US6534642 Isolated nucleic acid of given sequence encoding a protein; dysfunction of the human protein implicated in hyper/hypocalcemia, bone disorders, leukemia and cancer
03/18/2003US6534641 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease.
03/18/2003US6534638 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
03/18/2003US6534633 Polyspecific binding molecules and uses thereof
03/18/2003US6534482 Expression vectors for stimulating an immune response and methods of using the same
03/18/2003US6534476 Smad6 and uses thereof
03/18/2003US6534290 Methods for production of growth-promoting proteins and peptides for kidney epithelial cells
03/18/2003US6534285 Composition comprising predetermined polypeptide sequence of AIDS-associated retrovirus comprising at least one antigenic determinant that specifically binds complementary antibody
03/18/2003US6534277 Method for identifying a compound to be tested for an ability to reduce immune rejection by determining Stat4 and Stat6 proteins
03/18/2003US6534067 Rotavirus enterotoxin adjuvant
03/18/2003US6534066 Inactivated vaccine against feline calicivirosis
03/18/2003US6534065 Influenza vaccine composition with chitosan adjuvant
03/18/2003US6534064 Herpes simplex virus type 2 glycoprotein B, hepatitis C virus or a human immunodeficiency virus protein as an antigen
03/18/2003US6534062 Administering an immunostimulatory nucleic acid molecule in an amount effective to increase antigen-specific cytotoxic T lymphocyte (CTL) activity in a CD4+ T cell-deficient individual
03/18/2003US6534061 Isolated DNA98853 and DNA101848 polypeptides
03/18/2003US6534059 Administering to the eye of said mammal a composition comprising antibody to interferon gamma.
03/18/2003US6534056 Therapeutic and diagnostic uses of protein tyrosine phosphatase TC-PTP
03/18/2003US6534055 Methods for selectively stimulating proliferation of T cells
03/18/2003US6534036 Biological materials and methods useful in the diagnosis and treatment of diseases
03/18/2003CA2220347C Compositions and methods for detecting and treating acquired immunodeficiency syndrome
03/18/2003CA2121370C Specific tolerance in transplantation
03/18/2003CA2092519C Synthetic polypeptides as inhibitors of hiv-1
03/18/2003CA1341425C Antibodies to angiogenin: immunotherapeutic agents
03/14/2003WO2003025166A1 Therapeutic vaccination method, mutated peptides of hiv reverse transcriptase and their use for vaccination and diagnostic purposes
03/14/2003CA2460377A1 Therapeutic vaccination method, mutated peptides of hiv reverse transcriptase and their use for vaccination and diagnostic purposes
03/13/2003WO2003021273A2 Diagnosis of carcinomas
03/13/2003WO2003020954A2 205p1b5 in treatment and detection of cancer
03/13/2003WO2003020949A2 Targeted nucleic acid constructs and uses related thereto
03/13/2003WO2003020934A1 Compositions and methods relating to colon specific genes and proteins
03/13/2003WO2003020917A1 Improved methods for producing oocysts
03/13/2003WO2003020909A2 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders
03/13/2003WO2003020900A2 Compositions and methods relating to breast specific genes and proteins
03/13/2003WO2003020893A2 New adenovirus type 7 vectors
03/13/2003WO2003020884A2 Method for rapid generation of mature dendritic cells
03/13/2003WO2003020876A2 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
03/13/2003WO2003020875A2 Staphylococci surface-exposed immunogenic polypeptides
03/13/2003WO2003020768A1 A method for the treatment or prevention of bone erosion
03/13/2003WO2003020767A2 Antibodies against caspase-8, their preparation and use